ANI Pharmaceuticals (ANIP) Stock Statistics & Valuation Metrics

ANI Pharmaceuticals has a market cap or net worth of $1.47B. The enterprise value is $1.58B.

ANI Pharmaceuticals has 21.57M shares outstanding. The number of shares has decreased by -2.65% in one year.

ANI Pharmaceuticals’s return on equity (ROE) is -0.04 and return on invested capital (ROIC) is 0.04%.

The current PE Ratio of ANI Pharmaceuticals is -57.66. ANI Pharmaceuticals’s PEG ratio is 0.30.

In the last 12 months, ANI Pharmaceuticals had revenue of $614.38M and earned -$18.52M in profits. Earnings per share was -$1.08.

In the last 12 months, operating cash flow was $64.02M and capital expenditures -$16.95M, giving a free cash flow of $47.06M billion.

ANI Pharmaceuticals pays an annual dividend of , resulting in a dividend yield of

ANI Pharmaceuticals upcoming earnings date is May 9, 2025, Before Open.

ANI Pharmaceuticals as a current ratio of 2.72, with Debt / Equity ratio of 0.74

In the past 12 months, ANI Pharmaceuticals has paid -$3.69M in taxes.

ANI Pharmaceuticals EV to EBITDA ratio is 19.61, with an EV/FCF ratio of 19.34.

ANI Pharmaceuticals has $151.17M in cash and marketable securities with $314.98M in debt, giving a net cash position of $163.82M billion.

Gross margin is 100.00%, with operating margin of 0.10%, and net profit margin of -3.01%.

The average price target for ANI Pharmaceuticals is $85.00, which is 11.43% higher than the current price. The consensus rating is Strong Buy